Trials / Completed
CompletedNCT00792311
Tsui Test as a Predictor of Bupivacaine Consumption in Labour Epidurals
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Low current electrical stimulation test, also called the Tsui test, has been used successfully to confirm the catheter location in the epidural space in various patient populations. The results of this study will show whether or not doing a Tsui test can predict inadequate epidural analgesia early in the course of placing the epidural, so that the appropriate measures could be applied immediately upon gathering unfavorable results.
Detailed description
Despite its very high success rate, the epidural technique remains a rather blind technique, and failures continue to occur. The incidence and reasons for failure are not well understood. The Tsui test is not routinely performed with each epidural catheter insertion, but rather it is used when there is suspicion about the catheter location. In this study, the Tsui test will be performed twice during the epidural procedure, and bupivacaine consumption will be recorded for the first 2 hours. Information gained from this study could have great impact in clinical practice, since the incidence of inadequate labor analgesia is still relatively high (10-20%), leading to maternal distress and disappointing labor experience.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Tsui test | The stimulator is set at frequency of 1Hz with 200ms pulse width and the current output ranging from 0 to 20 mA. The current output will be carefully increased from zero until motor activity is detected up to a maximum of 20 mA. |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2008-11-17
- Last updated
- 2010-03-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00792311. Inclusion in this directory is not an endorsement.